Ash
The first AI designed for therapy and mental health support
Company profile
Company profile
Slingshot AI is building what it calls a foundation model for psychology, addressing the global mental health crisis through artificial intelligence. The company's flagship product, Ash, is the first AI specifically designed for therapy rather than as a general assistant. Unlike traditional AI chatbots that provide answers, Ash is designed to increase users' sense of autonomy, competence, and relatedness by questioning like a therapist and holding users accountable. The platform learns from multiple therapeutic approaches including CBT, DBT, ACT, gestalt, and psychodynamic therapy, recognizing that different approaches work for different people. Slingshot AI was founded in January 2024 by Daniel Cahn and Neil Parikh (co-founder of Casper). After 18 months of development with over 50,000 beta users including therapists, Ash launched publicly in July 2025 as a free iOS and Android app. The company's mission is to make mental healthcare more accessible and help people change their lives in the ways they want, leveraging Large Language Models to provide deeply personalized support that respects individual value systems and cultural norms.
Company description Slingshot AI official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Public launch of Ash app in July 2025 after 18 months of development. Extended Series A funding announced July 2025, bringing total raised to $93M. Beta program reached 50,000 users.
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
The first AI designed for therapy and mental health support
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
American journal of health promotion : AJHP · Feb 1, 2026
Beyond Simulations: What 20,000 Real Conversations Reveal About Mental Health AI Safety.Research square · Jan 27, 2026
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Users report feeling more in control of their lives
Users gain confidence they can manage their challenges
Users feel more connected while maintaining human relationships
User testimonials report overcoming anxiety and rumination
Mental health support for anxiety, rumination, and general psychological wellbeing
25,000 beta users tested the platform with positive feedback on overcoming anxious thoughts and ruminations
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Slingshot AI's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.